5 studies found for:    Open Studies | "Multiple Endocrine Neoplasia"
Show Display Options
Rank Status Study
1 Recruiting Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2B
Intervention: Drug: ZACTIMA (Vandetanib)
2 Recruiting Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
Conditions: Gastrinoma;   Glucagonoma;   Insulinoma;   Metastatic Gastrointestinal Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Pancreatic Polypeptide Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Regional Gastrointestinal Carcinoid Tumor;   Somatostatinoma;   WDHA Syndrome
Intervention: Drug: pazopanib hydrochloride
3 Recruiting Studies of Inherited Diseases of Metabolism
Conditions: Hypercalcemia;   Hyperparathyroidism;   Multiple Endocrine Neoplasia
Intervention:
4 Recruiting Natural History Study of Children and Young Adults With Medullary Thyroid Cancer
Condition: Medullary Thyroid Carcer
Intervention:
5 Recruiting Diagnosis of Pheochromocytoma
Condition: Pheochromocytoma
Intervention:

Indicates status has not been verified in more than two years